VIP LIVEALERTS-PRO BioCardia FDA Approval BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure [Nasdaq: BCDA], BioCardia, Inc. a developer of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases, announced FDA approval of its Phase III clinical trial for CardiAMP autologous cell therapy in treating […]
VIP LIVEALERTS-PRO Barbie Woes Loom As Shares Tank Barbie Boosts Profits, but Strikes and Ad Market Woes Loom Warner Bros Discovery (WBD) has exceeded core quarterly profit estimates due to the blockbuster success of “Barbie” at the box office. However, ongoing Hollywood strikes and a sluggish advertising market could impact earnings into the next year. […]
VIP LIVEALERTS-PRO PaxMedica shares surge 180% PaxMedica Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed Journal Tuesday, 07 November 2023 08:00 TARRYTOWN, NY / ACCESSWIRE / November 7, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, announced the publication of research findings in the Annals […]
Traders rejoiced as the Federal Reserve announced a potential end to rate hikes, sparking a market rally. Speculation ran rampant as investors eagerly anticipated the implications of this shift in monetary policy. With hopes of increased economic growth and reduced borrowing costs, the market surged, leaving traders optimistic about the future.
VipLiveAlerts-Pro AI has launched a groundbreaking financial application, offering users real-time market data, real-time personalized alerts, and advanced analytics. With seamless API integrations, users can access their favorite news platforms and execute trades effortlessly. Collaborating with top news sources, the app ensures users stay informed with the latest financial news and trends.
VIP LIVEALERTS-PRO Biocept Signs CNSide™ Licensing Agreement Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics September 08, 2023 08:00 AM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products, and services, announces the signing of a non-exclusive licensing agreement for CNSide™ with Plus Therapeutics, Inc. (Nasdaq: PSTV) […]
VIP LIVEALERTS-PRO Taysha Gene Therapies, Inc Taysha gene therapies reports initial clinical data from first adult rett syndrome patient dosed in reveal phase 1/2 trial and provides corporate update with second quarter 2023 financial results Data from first adult patient dosed in REVEAL Phase 1/2 trial showed TSHA-102 was well-tolerated with no treatment-emergent serious adverse […]
VIP LIVEALERTS-PRO Missfresh Share Purchase Agreements Missfresh Announces Entry of Share Purchase Agreements for Financing and Business Acquisition BEIJING, Aug. 03, 2023 (GLOBE NEWSWIRE) — Missfresh Limited (“Missfresh” or the “Company”) (NASDAQ: MF), today announced that it entered into two share purchase agreements with two investors, respectively (the “Share Purchase Agreements for Financing”), and another […]
Threads by Meta, the new Twitter alternative, has taken the digital world by storm, amassing a staggering 10 million downloads in a record-breaking time. With its sleek interface and innovative features, Threads offers users a refreshing and promising social media experience. It seems that the era of Twitter dominance may be coming to an end.
VIP LIVEALERTS-PRO Walgreens Boots Alliance Walgreens Boots Alliance Sells Remaining Shares of Option Care Health for Approximately $330 Million of Proceeds Transaction Highlights Walgreens Boots Alliance announces the sale of its remaining shares of Option Care Health for proceeds of approximately $330 million Proceeds to Walgreens Boots Alliance will be used primarily for debt paydown, […]